What to know about Germany's government crisis | AP News
5 days ago · Five things to know about Germany’s government crisis. Federal Chancellor Olaf Scholz leaves the plenary chamber of the Bundestag during the debate following his government statement, in Berlin, Wednesday, Nov. 13. 2024. (Michael Kappeler/dpa via AP) Opposition leader Friedrich Merz of the Christian Democrats delivers a speech while German ...
Friedrich Merz, the man who would be Germany’s next chancellor
3 days ago · Carsten Linnemann, the CDU general secretary, who has known him for years, says Merz was made for the turbulent times Germany and the world now face, with Donald Trump soon to return to the White ...
Merz Therapeutics Closes $185M Asset Purchase Agreement with …
Jul 10, 2024 · Merz Therapeutics Closes $185M Asset Purchase Agreement with Acorda Therapeutics. Acquisition of INBRIJA (levodopa inhalation powder) and (F)AMPYRA (fampridine) expands specialty neurology portfolio. Lays groundwork for Parkinson’s disease franchise and anchor in multiple sclerosis therapy.
Merz Opens Door to Reform Germany’s Strict Borrowing Limits
5 days ago · Conservative chancellor candidate Friedrich Merz said he’s open to reform Germany’s strict borrowing limits as long as additional debt-financed spending is used for investment.
Friedrich Merz:CDU leader sets sights on becoming German …
BERLIN, Sept 17 (Reuters) - Squeezed out of top-level politics by his arch party rival Angela Merkel more than two decades ago, Friedrich Merz is on course to land his first ever government...
Merz to expand and hunt for more deals after closing Inbrija buy
Jul 11, 2024 · After $185M asset buy, Merz Therapeutics plots US workforce expansion as CEO eyes more deals. Freshly equipped with two approved meds from Acorda Therapeutics, Frankfurt, Germany’s Merz ...
News - Merz Pharma
Mar 1, 2023 · Merz enters Asset Purchase Agreement with a US-based biotech company. Second investment in a NASDAQ company in just over ten years. Frankfurt am Main, Germany / April 1, 2024 / Merz Therapeutics, a business of Frankfurt-based Merz Group, has entered….
Merz Therapeutics Closes $185M Asset Purchase Agreement with …
Jul 10, 2024 · The completion of this deal, valued at USD 185 million in cash, bolsters Merz Therapeutics’ market position by enhancing offerings for people living with Parkinson’s disease and expanding into...
Merz Enters Asset Purchase Agreement With a US-Based Biotech …
Apr 2, 2024 · FRANKFURT AM MAIN, Germany, April 02, 2024 -- (BUSINESS WIRE)-- Merz Therapeutics, a business of Frankfurt-based Merz Group, has entered into an Asset Purchase Agreement to acquire two commercial...
Acorda Therapeutics Inc - Acorda Therapeutics and Merz …
Apr 1, 2024 · PEARL RIVER, N.Y.-- (BUSINESS WIRE)-- Acorda Therapeutics, Inc. (Nasdaq: ACOR) (“Acorda” or “the Company”) today announced that it has entered into an asset purchase agreement with Merz Therapeutics to purchase substantially all of the assets of Acorda, including the rights to INBRIJA, AMPYRA, and FAMPYRA for $185 million.
- Some results have been removed